A Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis
- 20 October 1994
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (16), 1091-1092
- https://doi.org/10.1056/nejm199410203311613
Abstract
Few diseases are as debilitating and inevitably lethal as amyotrophic lateral sclerosis (ALS). The disease typically strikes adults in midlife, causing paralysis and death within five years. The cause of most cases remains unknown, and the disease is untreatable. About 10 percent of patients have an inherited form of the disease. In 1993 a multicenter study reported that some cases of familial ALS arise because of mutations in the gene encoding the cytosolic form of the enzyme copper-zinc superoxide dismutase (SOD1).1 This enzyme detoxifies the superoxide anion, a ubiquitous byproduct of aerobic metabolism. As a free radical (free to diffuse . . .Keywords
This publication has 6 references indexed in Scilit:
- Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase MutationScience, 1994
- A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosisHuman Molecular Genetics, 1994
- Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral SclerosisJournal of Neurochemistry, 1993
- Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide DismutaseScience, 1993
- ALS, SOD and peroxynitriteNature, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993